药品注册申请号:016831
申请类型:NDA (新药申请)
申请人:EXTROVIS
申请人全名:EXTROVIS AG
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 EFUDEX FLUOROURACIL SOLUTION;TOPICAL 2% Yes Yes AT 1970/07/29 Approved Prior to Jan 1, 1982 Prescription
002 EFUDEX FLUOROURACIL SOLUTION;TOPICAL 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No None Approved Prior to Jan 1, 1982 Discontinued
003 EFUDEX FLUOROURACIL CREAM;TOPICAL 5% Yes Yes AB Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2021/10/14 SUPPL-63(补充) Approval Labeling STANDARD
2015/11/04 SUPPL-59(补充) Approval Manufacturing (CMC) STANDARD
2015/08/18 SUPPL-58(补充) Approval Manufacturing (CMC) STANDARD
2015/05/06 SUPPL-57(补充) Approval Manufacturing (CMC) STANDARD
2013/12/12 SUPPL-55(补充) Approval Manufacturing (CMC) STANDARD
2013/07/02 SUPPL-56(补充) Approval Manufacturing (CMC) STANDARD
2006/05/10 SUPPL-51(补充) Approval Manufacturing (CMC) N/A
2005/10/13 SUPPL-49(补充) Approval Labeling STANDARD
2004/06/24 SUPPL-47(补充) Approval Labeling STANDARD
2004/04/27 SUPPL-46(补充) Approval Manufacturing (CMC) STANDARD
2002/11/27 SUPPL-43(补充) Approval Manufacturing (CMC) STANDARD
2001/08/30 SUPPL-42(补充) Approval Manufacturing (CMC) STANDARD
2001/07/03 SUPPL-41(补充) Approval Manufacturing (CMC) STANDARD
2001/07/03 SUPPL-40(补充) Approval Manufacturing (CMC) STANDARD
2001/02/12 SUPPL-39(补充) Approval Manufacturing (CMC) STANDARD
2000/07/07 SUPPL-37(补充) Approval Manufacturing (CMC) STANDARD
2000/07/07 SUPPL-36(补充) Approval Manufacturing (CMC) STANDARD
2000/06/20 SUPPL-38(补充) Approval Manufacturing (CMC) STANDARD
2000/04/05 SUPPL-35(补充) Approval Manufacturing (CMC) STANDARD
1998/11/02 SUPPL-33(补充) Approval Manufacturing (CMC) STANDARD
1997/02/18 SUPPL-32(补充) Approval Manufacturing (CMC) STANDARD
1995/03/21 SUPPL-29(补充) Approval Labeling
1993/08/05 SUPPL-31(补充) Approval Manufacturing (CMC) STANDARD
1993/03/04 SUPPL-30(补充) Approval Manufacturing (CMC) STANDARD
1988/11/30 SUPPL-28(补充) Approval Manufacturing (CMC) STANDARD
1987/03/26 SUPPL-17(补充) Approval Labeling
1986/11/14 SUPPL-27(补充) Approval Manufacturing (CMC) STANDARD
1985/06/10 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
1985/03/14 SUPPL-25(补充) Approval Manufacturing (CMC) STANDARD
1984/08/13 SUPPL-24(补充) Approval Manufacturing (CMC) STANDARD
1984/05/04 SUPPL-23(补充) Approval Manufacturing (CMC) STANDARD
1983/08/12 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
1983/08/12 SUPPL-21(补充) Approval Manufacturing (CMC) STANDARD
1983/03/14 SUPPL-20(补充) Approval Manufacturing (CMC) STANDARD
1982/05/14 SUPPL-19(补充) Approval Manufacturing (CMC) STANDARD
1982/03/10 SUPPL-18(补充) Approval Labeling
1979/12/18 SUPPL-16(补充) Approval Manufacturing (CMC) STANDARD
1979/10/23 SUPPL-15(补充) Approval Manufacturing (CMC) STANDARD
1978/11/21 SUPPL-14(补充) Approval Manufacturing (CMC) STANDARD
1977/12/14 SUPPL-13(补充) Approval Manufacturing (CMC) STANDARD
1977/12/14 SUPPL-12(补充) Approval Manufacturing (CMC) STANDARD
1975/06/30 SUPPL-8(补充) Approval Manufacturing (CMC) STANDARD
1975/05/07 SUPPL-11(补充) Approval Manufacturing (CMC) STANDARD
1975/05/07 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
1974/09/19 SUPPL-9(补充) Approval Manufacturing (CMC) STANDARD
1970/07/29 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:FLUOROURACIL 剂型/给药途径:SOLUTION;TOPICAL 规格:2% 治疗等效代码:AT
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
016831 001 NDA EFUDEX FLUOROURACIL SOLUTION;TOPICAL 2% Prescription Yes Yes AT Approved Prior to Jan 1, 1982 EXTROVIS
076526 001 ANDA FLUOROURACIL FLUOROURACIL SOLUTION;TOPICAL 2% Prescription No No AT 2003/11/05 TARO
活性成分:FLUOROURACIL 剂型/给药途径:CREAM;TOPICAL 规格:5% 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
016831 003 NDA EFUDEX FLUOROURACIL CREAM;TOPICAL 5% Prescription Yes Yes AB Approved Prior to Jan 1, 1982 EXTROVIS
077524 001 ANDA FLUOROURACIL FLUOROURACIL CREAM;TOPICAL 5% Prescription No No AB 2008/04/11 DR REDDYS LABS SA
090368 001 ANDA FLUOROURACIL FLUOROURACIL CREAM;TOPICAL 5% Prescription No No AB 2010/03/05 TARO
214845 001 ANDA FLUOROURACIL FLUOROURACIL CREAM;TOPICAL 5% Prescription No No AB 2021/10/07 ACCORD HLTHCARE
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database